Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kenvue Inc. Common Stock (KVUE) vs Solstice Advanced Materials Inc. Common Stock (SOLS) Price & Performance

Kenvue Inc. Common StockTrade
Solstice Advanced Materials Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Kenvue Inc. Common Stock vs Solstice Advanced Materials Inc. Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $18.12 (market cap $34.11B), while Solstice Advanced Materials Inc. Common Stock trades at $59.92 (market cap $9.68B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.5× Solstice Advanced Materials Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.73%). Which is the better fit depends on your goals — on Pluang, investors hold Kenvue Inc. Common Stock for 1 Days and Solstice Advanced Materials Inc. Common Stock for 0 Days on average.

KVUESOLS
Market Cap
$34.11B$9.68B
Volume
27,388,8111,519,067
Sector
Consumer StaplesBasic Materials
52-Week High
$19.83$88.60
52-Week Low
$14.11$41.43
Typical Hold Time
1 Days0 Days
Enterprise Value
$41.62B$11.35B
Dividend Yield
4.73%0.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kenvue Inc. Common Stock

Kenvue (KVUE) trades at $17.76, down 0.39% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $15.12B in 2025, with a net income margin of 10.76% and a P/E ratio of 20.89. Recent news highlights conditional EU approval for Kimberly-Clark's $40B acquisition of Kenvue, potentially impacting future operations and shareholder returns.

The outlook is mixed, with strong profitability and consistent dividend payments offering stability, but the pending acquisition introduces uncertainty. Risks include integration challenges and market volatility. Analyst consensus is a Hold with a $19.50 price target, suggesting limited near-term upside from current levels.

Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials (SOLS) trades at $60.91, up 0.33% with neutral technical signals. The company shows strong profitability with 30.64% gross margins and 14.95% ROE, though Q4 2025 earnings missed expectations. Recent developments include a $49M R&D expansion and termination of the Element Solutions merger, with the board authorizing a $500M share repurchase program. Analyst consensus is bullish with 80% buy ratings and a $80.22 price target representing 32% upside potential.

SOLS presents a compelling growth story with consistent earnings beats and institutional accumulation, though elevated P/E of 46.07 warrants caution. Key risks include execution challenges post-merger termination and margin pressure as profit margins declined from 6.09% to 5.12% year-over-year. The stock offers substantial upside if management delivers on growth initiatives while maintaining current profitability levels.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KVUE

No sentiment data available yet.

SOLS
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →

About Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials Inc. is a specialty materials company spun off from Honeywell in 2025, producing low-global-warming-potential refrigerants, blowing agents, and industrial solvents through its Refrigerants and Applied Solutions segment. Its Electronic and Specialty Materials segment supplies semiconductor materials, high-strength fibers, and healthcare-packaging films.

Read more on SOLS →